BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36418206)

  • 1. Multiple Lugol-unstained lesions predict higher cumulative risk of malignance in the esophagus.
    Qi Z; Liu M; Zhou R; Guo C; Liu A; Yang H; Li F; Duan L; Shen L; Wu Q; Wu N; Liu Z; Pan Y; Liu F; Liu Y; Cai H; He Z; Ke Y
    J Gastroenterol Hepatol; 2023 Mar; 38(3):416-423. PubMed ID: 36418206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How should extra-large Lugol-unstained lesions of the esophagus be treated? Results from a population-based cohort study.
    Liu M; Qi Z; Zhou R; Guo C; Liu A; Yang H; Li F; Duan L; Shen L; Wu Q; Liu Z; Pan Y; Liu F; Liu Y; Cai H; He Z; Ke Y
    Cancer Med; 2023 Oct; 12(19):20129-20139. PubMed ID: 37732496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lugol-unstained lesions location in the esophagus affects the detection rate of malignancy: a population-based study.
    Qin J; Liu M; Liu A; Guo C; Qi Z; Zhou R; Yang H; Li F; Duan L; Shen L; Wu Q; Liu Z; Pan Y; Liu F; Liu Y; Cai H; He Z; Ke Y
    J Gastroenterol Hepatol; 2023 Dec; 38(12):2167-2173. PubMed ID: 37726891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Size of Lugol-unstained lesions as a predictor for risk of progression in premalignant lesions of the esophagus.
    Liu M; Zhou R; Guo C; Xu R; Liu A; Yang H; Li F; Duan L; Shen L; Wu Q; Liu Z; Liu F; Liu Y; Pan Y; Cai H; Weiss NS; He Z; Ke Y
    Gastrointest Endosc; 2021 May; 93(5):1065-1073.e3. PubMed ID: 32950597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult dysplasia is disclosed by Lugol chromoendoscopy in alcoholics at high risk for squamous cell carcinoma of the esophagus.
    Fagundes RB; de Barros SG; Pütten AC; Mello ES; Wagner M; Bassi LA; Bombassaro MA; Gobbi D; Souto EB
    Endoscopy; 1999 May; 31(4):281-5. PubMed ID: 10376452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of p53 gene alteration as a biomarker to evaluate the malignant risk of Lugol-unstained lesion with non-dysplasia in the oesophagus.
    Kaneko K; Katagiri A; Konishi K; Kurahashi T; Ito H; Kumekawa Y; Yamamoto T; Muramoto T; Kubota Y; Nozawa H; Makino R; Kushima M; Imawari M
    Br J Cancer; 2007 Feb; 96(3):492-8. PubMed ID: 17285122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of Lugol staining indicates initiation of esophageal squamous cell carcinoma: A combined genomic and epidemiologic study.
    Liu Z; Liu M; Liu Y; Zhou R; Abliz A; Yuan W; Guo C; Zhang L; He W; Zheng H; Huang Y; Pan Y; Liu F; Hu Z; Chen H; Cai H; He Z; Ke Y
    Cell Rep Med; 2023 Sep; 4(9):101168. PubMed ID: 37625408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Model To Identify Individuals at High Risk for Esophageal Squamous Cell Carcinoma and Precancerous Lesions in Regions of High Prevalence in China.
    Liu M; Liu Z; Cai H; Guo C; Li X; Zhang C; Wang H; Hang D; Liu F; Deng Q; Yang X; Yuan W; Pan Y; Li J; Zhang C; Shen N; He Z; Ke Y
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1538-1546.e7. PubMed ID: 28342951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for dysplasia with Lugol chromoendoscopy in longstanding idiopathic achalasia.
    Ponds FA; Moonen A; Smout AJPM; Rohof WOA; Tack J; van Gool S; Bisschops R; Bredenoord AJ; Boeckxstaens GE
    Am J Gastroenterol; 2018 Jun; 113(6):855-862. PubMed ID: 29748564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic findings corresponding to multiple Lugol-voiding lesions in the esophageal background mucosa.
    Matsuno K; Ishihara R; Nakagawa K; Ohmori M; Iwagami H; Inoue S; Iwatsubo T; Nakahira H; Matsuura N; Shichijyo S; Maekawa A; Takashi K; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Matsunaga T
    J Gastroenterol Hepatol; 2019 Feb; 34(2):390-396. PubMed ID: 30101499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating synchronous esophageal cancer in head and neck cancer patients using Lugol dye chromoendoscopy.
    Laohawiriyakamol S; Sunpaweravong S; Leelamanit V; Pruegsanusak K; Sinkijcharoenchai W
    J Med Assoc Thai; 2014 Nov; 97(11):1164-70. PubMed ID: 25675681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer.
    Muto M; Hironaka S; Nakane M; Boku N; Ohtsu A; Yoshida S
    Gastrointest Endosc; 2002 Oct; 56(4):517-21. PubMed ID: 12297767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of Iodine Staining Associates With Progression of Esophageal Lesions in a Prospective Endoscopic Surveillance Study in China.
    Liu M; Liu Z; Liu F; Guo C; Xu R; Li F; Liu A; Yang H; Zhang S; Shen L; Duan L; Wu Q; Cao C; Pan Y; Liu Y; Li J; Cai H; He Z; Ke Y
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1626-1635.e7. PubMed ID: 31518715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristic of esophageal cancer without lugol-voiding lesions in the background esophagus.
    Kuwabara H; Chiba H; Tachikawa J; Okada N; Ashikari K; Arimoto J; Nakaoka M; Sakai E; Goto T; Ohata K
    Dig Endosc; 2020 May; 32(4):621-627. PubMed ID: 31965622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with the presence of multiple Lugol-voiding lesions in patients with esophageal squamous-cell carcinoma.
    Katada C; Muto M; Tanabe S; Higuchi K; Sasaki T; Azuma M; Ishido K; Katada N; Sakuramoto S; Yamashita K; Masaki T; Nakayama M; Okamoto M; Koizumi W
    Dis Esophagus; 2014 Jul; 27(5):457-62. PubMed ID: 23009284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol Consumption and Multiple Dysplastic Lesions Increase Risk of Squamous Cell Carcinoma in the Esophagus, Head, and Neck.
    Katada C; Yokoyama T; Yano T; Kaneko K; Oda I; Shimizu Y; Doyama H; Koike T; Takizawa K; Hirao M; Okada H; Yoshii T; Konishi K; Yamanouchi T; Tsuda T; Omori T; Kobayashi N; Shimoda T; Ochiai A; Amanuma Y; Ohashi S; Matsuda T; Ishikawa H; Yokoyama A; Muto M
    Gastroenterology; 2016 Nov; 151(5):860-869.e7. PubMed ID: 27492616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lugol chromoendoscopy combined with brush cytology in patients at risk for esophageal squamous cell carcinoma.
    Boller D; Spieler P; Schoenegg R; Neuweiler J; Kradolfer D; Studer R; Grossenbacher R; Zuercher U; Meyenberger C; Borovicka J
    Surg Endosc; 2009 Dec; 23(12):2748-54. PubMed ID: 19444514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromoendoscopy and magnification endoscopy for diagnosing esophageal cancer and dysplasia.
    Connor MJ; Sharma P
    Thorac Surg Clin; 2004 Feb; 14(1):87-94. PubMed ID: 15382312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delineating the extent of esophageal squamous cell carcinoma.
    Kono M; Kanesaka T; Ishihara R; Kitamura M; Shoji A; Inoue T; Matsueda K; Miyake M; Waki K; Shimamoto Y; Fukuda H; Iwagami H; Matsuura N; Nakahira H; Shichijo S; Maekawa A; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Michida T; Nakatsuka SI; Fujiwara Y
    Esophagus; 2021 Oct; 18(4):790-796. PubMed ID: 34052934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lugol chromoendoscopy as a diagnostic tool in so-called endoscopy-negative GERD.
    Yoshikawa I; Yamasaki M; Yamasaki T; Kume K; Otsuki M
    Gastrointest Endosc; 2005 Nov; 62(5):698-703; quiz 752, 754. PubMed ID: 16246682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.